Schranz DB - Search Results

1

Incubation of MDCO-216 (ApoA-IMilano/POPC) with Human Serum Potentiates ABCA1-Mediated Cholesterol Efflux Capacity, Generates New Prebeta-1 HDL, and Causes an Increase in HDL Size.

Kempen HJ, Schranz DB, Asztalos BF, Otvos J, Jeyarajah E, Drazul-Schrader D, Collins HL, Adelman SJ, Wijngaard PL. Kempen HJ, et al. Among authors: schranz db. J Lipids. 2014;2014:923903. doi: 10.1155/2014/923903. Epub 2014 Nov 12. J Lipids. 2014. PMID: 25478232 Free PMC article.

2

Phase 0 study of the inhibition of cholesteryl ester transfer protein activity by JNJ-28545595 in plasma from normolipidemic and dyslipidemic humans.

Sarich TC, Connelly MA, Schranz DB, Ghosh A, Manitpisitkul P, Leary ET, Rothenberg P, Demarest KT, Damiano BP. Sarich TC, et al. Among authors: schranz db. Int J Clin Pharmacol Ther. 2012 Aug;50(8):584-94. doi: 10.5414/CP201627. Int J Clin Pharmacol Ther. 2012. PMID: 22578199

3

Newly diagnosed latent autoimmune diabetes in adults (LADA) is associated with low level glutamate decarboxylase (GAD65) and IA-2 autoantibodies. Diabetes Incidence Study in Sweden (DISS).

Schranz DB, Bekris L, Landin-Olsson M, Törn C, Niläng A, Toll A, Sjöström J, Grönlund H, Lernmark A. Schranz DB, et al. Horm Metab Res. 2000 Apr;32(4):133-8. doi: 10.1055/s-2007-978607. Horm Metab Res. 2000. PMID: 10824708

4

Glutamate decarboxylase (GAD) autoantibody epitope shift during the first year of type 1 diabetes.

Hampe CS, Ortqvist E, Persson B, Schranz DB, Lernmark A. Hampe CS, et al. Among authors: schranz db. Horm Metab Res. 1999 Oct;31(10):553-7. doi: 10.1055/s-2007-978794. Horm Metab Res. 1999. PMID: 10596964

5

Species-specific autoantibodies in type 1 diabetes.

Hampe CS, Ortqvist E, Rolandsson O, Landin-Olsson M, Törn C, Agren A, Persson B, Schranz DB, Lernmark A. Hampe CS, et al. Among authors: schranz db. J Clin Endocrinol Metab. 1999 Feb;84(2):643-8. doi: 10.1210/jcem.84.2.5503. J Clin Endocrinol Metab. 1999. PMID: 10022431

6

A simple and rapid microSepharose assay for GAD65 and ICA512 autoantibodies in diabetes. Diabetes Incidence Study in Sweden (DISS).

Schranz DB, Bekris L, Landin-Olsson M, Törn C, Niläng A, Toll A, Grönlund H, Toivola B, Lernmark A. Schranz DB, et al. J Immunol Methods. 1998 Apr 1;213(1):87-97. doi: 10.1016/s0022-1759(98)00025-8. J Immunol Methods. 1998. PMID: 9671127

7

Immunology in diabetes: an update.

Schranz DB, Lernmark A. Schranz DB, et al. Diabetes Metab Rev. 1998 Mar;14(1):3-29. doi: 10.1002/(sici)1099-0895(199803)14:1<3::aid-dmr206>3.0.co;2-t. Diabetes Metab Rev. 1998. PMID: 9605628 Review.

8

Insulin internalization in the absence of the insulin receptor tyrosine kinase domain is insufficient for mediating intracellular biological effects.

Schranz DB, Rohilla AM, Anderson C, Wood WM, Berhanu P. Schranz DB, et al. Biochem Biophys Res Commun. 1996 Oct 14;227(2):600-7. doi: 10.1006/bbrc.1996.1552. Biochem Biophys Res Commun. 1996. PMID: 8878559

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Search Page

Filters